Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-10-11

FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for mefloquine hydrochloride (Teva), indicating changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mefloquine hydrochloride (Mefloquine hydrochloride)

Snippet

SUPPL AP for MEFLOQUINE HYDROCHLORIDE (MEFLOQUINE HYDROCHLORIDE)